Evidence map›Paper›PMID 36738689›Full record

SynthesisJournal of infection and public health2023

Implications for COVID-19 vaccine uptake: A systematic review.

Peter Adu, Tosin Poopola, Oleg N Medvedev, Sunny Collings, James Mbinta, Clive Aspin, Colin R Simpson

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Journal of infection and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peter AduSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: adupe@staff.vuw.ac.nz.
Tosin PoopolaSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: tosin.popoola@vuw.ac.nz.
Oleg N MedvedevUniversity of Waikato, New Zealand. Electronic address: oleg.medvedev@waikato.ac.nz.
Sunny CollingsSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: sunny.collings@vuw.ac.nz.
James MbintaSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: james.mbinta@vuw.ac.nz.
Clive AspinSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: clive.aspin@vuw.ac.nz.
Colin R SimpsonSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand. Electronic address: colin.simpson@vuw.ac.nz.
Victoria University of Wellington · NZUniversity of Waikato · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally, increasing coronavirus disease (COVID-19) vaccination coverage remains a major public health concern in the face of high rates of COVID-19 hesitancy among the general population. We must understand the impact of the determinants of COVID-19 vaccine uptake when designing national vaccination programmes. We aimed to synthesise nationwide evidence regarding COVID-19 infodemics and the demographic, psychological, and social predictors of COVID-19 vaccination uptake.

methodsWe systematically searched seven databases between July 2021 and March 2022 to retrieve relevant articles published since COVID-19 was first reported on 31 December 2019 in Wuhan, China. Of the 12,502 peer-reviewed articles retrieved from the databases, 57 met the selection criteria and were included in this systematic review. We explored COVID-19 vaccine uptake determinants before and after the first COVID-19 vaccine roll-out by the Food and Drug Authority (FDA).

resultsIncreased COVID-19 vaccine uptake rates were associated with decreased hesitancy. Concerns about COVID-19 vaccine safety, negative side effects, rapid development of the COVID-19 vaccine, and uncertainty about vaccine effectiveness were associated with reluctance to be vaccinated. After the US FDA approval of COVID-19 vaccines, phobia of medical procedures such as vaccine injection and inadequate information about vaccines were the main determinants of COVID-19 vaccine hesitancy.

conclusionAddressing effectiveness and safety concerns regarding COVID-19 vaccines, as well as providing adequate information about vaccines and the impacts of pandemics, should be considered before implementation of any vaccination programme. Reassuring people about the safety of medical vaccination and using alternative procedures such as needle-free vaccination may help further increase vaccination uptake.

Indexed as

COVID-19VaccinesChinaCOVID-19 VaccinesHumansVaccinationVaccination CoverageCOVID-19 VaccinesVaccinesCOVID-19HesitancyInfodemicsVaccinationVaccine uptake

Identifiers

PMID36738689
PMCPMC9884645
OpenAlexW4319262320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.